If not administered properly, health experts say medications like Ozempic, Mounjaro, and Wegovy can cause gastrointestinal ...
(HealthDay News) — Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within one year, with higher discontinuation rates seen for those ...
16h
Daily Express US on MSNWeight loss drugs linked to blindness in new studyA study found that a popular diabetes drug also used for weight loss is linked in rare cases to vision problems as doctors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results